Posted by Michael Wonder on 19 Aug 2024
Most expensive treatments remain out of reach without health reform
18 August 2024 - Patients are waiting nearly 600 days to access medicines to which the Therapeutic Goods Administration has given the green light, new research has revealed, amid calls for reforms to the negotiation process with the pharmaceutical sector.
Pharmaceutical body Amgen’s Australian Patient Access Gap report shows patients wait an average 591 days to access medicine’s green-lit by the TGA between January 2021 and April this year through the Pharmaceutical Benefits Scheme.
